Designed to reinforce lucerastat as the first oral therapy suitable for all patients with Fabry disease, irrespective of their mutation type. The program is expected to support a potential regulatory ...

Physicists have watched a quantum fluid do something once thought almost impossible: stop moving. In experiments with ...

Low-temperature plasmas are intrinsically non-equilibrium systems in which electromagnetic fields, particle transport, and thermodynamic processes interact ...

Plasma propulsion transforms an inert propellant – often hydrogen – into plasma, a superheated mix of ions and electrons. Magnetic fields then funnel and accelerate the ...

"We studied the last several orbits before the merger, when the entwined magnetic fields undergo rapid and dramatic changes, and modeled potentially observable high-energy signals." ...

Researchers at the University of Colorado at Boulder have developed a groundbreaking plasma tunnel to simulate the extreme ...

Scientists recreate the early universe to study the first liquid ever formed and uncover how quarks moved through primordial matter.

Although large language models (LLMs) have the potential to transform biomedical research, their ability to reason accurately across complex, data-rich domains remains unproven. To address this ...

A strange, glowing form of matter called dusty plasma turns out to be incredibly sensitive to magnetic fields. Researchers found that even weak fields can change how tiny particles grow, simply by ...

Global Cold Plasma Market OverviewThe global cold plasma market is projected to grow at a robust compound annual growth rate of nearly 16% during the forecast period from 2026 to 2031, driven by its ...

Data from up to 42 months of treatment reinforce lucerastat’s potential as a first-in-class oral substrate reduction therapy addressing key unmet needs across the Fabry populationThe company is ...

The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...